21 February 2024 in bioRxiv
Expanded CAG/CTG repeats cause over 15 different diseases that all remain without a disease-modifying treatment. Because repeat length accounts for most of the variation in disease severity, contracting them presents an attractive therapeutic avenue. Here, we show that the CRISPR-Cas9 nickase targeted to CAG/CTG repeats leads to efficient contractions in Huntington’s disease patient-derived neurons and astrocytes, and in myotonic dystrophy type 1 patient-derived neurons. The approach is allele-selective and free of detectable off-target mutations. Striatal injection of the Cas9 nickase in a mouse model for Huntington’s disease using adeno-associated viral vectors led to contractions in over half the infected cells. Upon injection, we observed a reduction in the number of inclusion bodies, improved transcriptome, and ameliorated locomotion. The effects were greater than expected from the contractions induced and suggest that non-cell autonomous mechanisms may be involved. Our results provide the proof-of-concept that correction of CAG/CTG repeats can improve Huntington’s disease phenotypes in vivo . One sentence summary: The Cas9 nickase contracts CAG/CTG repeats at multiple disease loci in patient-derived cells and improves molecular and behavioral phenotypes in HD.
21 October 2026 in Science Translational Medicine
Expanded CAG/CTG repeats cause more than 15 different diseases that all remain without a disease-modifying treatment. Because repeat length accounts for most of the variation in disease severity, contracting CAG/CTG repeats presents an attractive therapeutic avenue. Here, we show that the CRISPR-Cas9 nickase targeted to CAG/CTG repeats leads to efficient repeat contractions in Huntington’s disease (HD) patient–derived neurons and astrocytes and in myotonic dystrophy type 1 patient–derived neurons. The approach was allele selective and free of detectable off-target mutations. Injection of the Cas9 nickase into the striatum of the R6/1 mouse model of HD using adeno-associated viral vectors led to repeat contractions in more than half of striatal neurons. Upon injection, we observed a reduction in the number of inclusion bodies, an improved gene expression profile, and amelioration of locomotion deficits in the open field test. The effects were greater than expected from the contractions induced, suggesting that non–cell autonomous mechanisms may be involved. Our results provide the proof of concept that correction of CAG/CTG repeats can improve HD phenotypes in a mouse disease model.
5 September 2021 in Journal of Neurology, Neurosurgery & Psychiatry
Background Longer CAG repeats in the HTT gene causes more severe forms of Huntington’s disease (HD), suggesting that contracting them would provide a much needed therapeutic benefit. We developed the first method to contract expanded repeats in human cell lines, whilst avoiding concomitant expansions. Unlike other systems that induce double strand breaks around the repeat tract to remove the repeat region, our method relies on the CRIPSR Cas9 nickase. The enzyme is targeted by a guide RNA against the repeat tract, resulting in nicks that are processed by the endogenous DNA repair machinery leading to contractions. The mechanism of contraction is poorly defined and identifying genetic players is important for both improving the contraction efficacy and for stratifying which patients would benefit best from this therapy. Aims Here we tested the hypothesis that loss of FAN1 impacts nickase-induced contractions. Methods/Techniques We generated a HEK293-derived cell line which contains a stably integrated CRISPR-Cas9 nickase, a sgRNA against the repeat tract and an inducible GFP-reporter system containing an ectopic CAG repeat. In this line, we also knocked out FAN1. We assayed for FAN1 loss of function using targeted DNA sequencing, western blotting, and sensitivity to mitomyocin C. We analysed repeat size using flow cytometry for GFP expression and by small-pool PCR. Results/Outcomes We found that two independent FAN1 knockout clones displayed an increase in the frequency of contraction events over 21 days. We found no effect on the frequency of expansion. Conclusions We conclude that FAN1 in our system prevents nickase-induced contractions without impacting expansion events.